Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Clinical Trial Photography and Video Recording – V 2.0

Posted on By

BA-BE Studies: SOP for Clinical Trial Photography and Video Recording – V 2.0

Standard Operating Procedure for Clinical Trial Photography and Video Recording in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/109/2025
Supersedes SOP/BA-BE/109/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a controlled and ethical procedure for capturing and managing photographic and video documentation during Bioequivalence (BE) studies in accordance with regulatory and ethical standards.

2. Scope

This SOP is applicable to all personnel involved in video recording or photography of informed consent processes, subject activities, dosing, or facility operations during BE studies.

3. Responsibilities

  • Clinical Research Coordinator (CRC): Coordinates and verifies audiovisual documentation and consent.
  • Investigator: Ensures recordings are conducted ethically and maintains participant rights and safety.
  • QA Officer: Reviews audiovisual files for compliance and retention.
  • IT/Data Manager: Maintains secure storage, access control, and backup of recorded files.
See also  BA-BE Studies: SOP for Handling Serious Adverse Events (SAEs) - V 2.0

4. Accountability

The Principal Investigator is accountable for ensuring that all audio-visual recordings are captured, stored, and accessed in accordance with ICH-GCP and Indian regulations.

5. Procedure

5.1 Consent for Photography and Video Recording

  1. Inform all participants about the purpose and scope of photography/video recording.
  2. Obtain separate, signed audiovisual consent using Annexure-1: AV Consent Form.
  3. Do not proceed with recording unless explicit consent is provided.

5.2 Recording Requirements

  1. Use approved, secure recording devices only.
  2. Ensure camera captures:
    • Full view of volunteer and investigator during consent discussion
    • Clear audio and video quality
  3. Recordings shall include:
    • Date and time stamp
    • Protocol title or number
    • Volunteer ID only (no full names)

5.3 Data Handling and Security

  1. Store recordings in encrypted, access-restricted folders.
  2. Label files using study ID, volunteer ID, and date (e.g., BE123_VOL109_170425).
  3. Maintain access logs (Annexure-2) for all view/download actions.
See also  BA-BE Studies: SOP for Reviewing Reference Product Literature - V 2.0

5.4 Retention and Backup

  1. Retain audiovisual recordings for at least 5 years or as per sponsor agreement.
  2. Back up recordings on a secure server or external encrypted device monthly.

5.5 Use and Disclosure

  1. Use recordings solely for study documentation, audit, or regulatory review.
  2. Any external use (e.g., training, publication) requires additional written consent from the subject.

5.6 Incident Management

  1. In case of:
    • Recording failure
    • Missing consent
    • Unauthorized access
  2. Document in Annexure-3: Recording Incident Log and initiate CAPA if needed.

6. Abbreviations

  • BE: Bioequivalence
  • PI: Principal Investigator
  • CRC: Clinical Research Coordinator
  • AV: Audio-Visual
  • CAPA: Corrective and Preventive Action

7. Documents

  1. AV Consent Form – Annexure-1
  2. Recording Access Log – Annexure-2
  3. Recording Incident Log – Annexure-3

8. References

  • ICH E6(R2) – Good Clinical Practice
  • Indian GCP Guidelines
  • Schedule Y – Drugs and Cosmetics Rules
  • CDSCO Guidance on AV Recording of Informed Consent
See also  BA-BE Studies: SOP for Emergency Medical Handling in BE Units - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: AV Consent Form

Volunteer ID Consent Given Signature Date Witness Name
VOL-109-004 Yes Signed 16/04/2025 Sunita Reddy

Annexure-2: Recording Access Log

Date Accessed By Role Purpose Signature
17/04/2025 Ajay Verma QA Audit Review Signed

Annexure-3: Recording Incident Log

Date Incident Description Reported By CAPA Initiated Verified By
15/04/2025 Mic issue in AV recording CRC Yes QA Officer

Revision History:

Revision Date Revision No. Details Reason Approved By
10/01/2022 1.0 Initial SOP Ethical Requirement QA Head
17/04/2025 2.0 Added annexures, access log, backup requirements Audit Observation QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: API Manufacturing: SOP for Use of Conductivity Meter in API Plant – V 2.0
Next Post: Analytical Method Development: Reagent Qualification for Method Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version